baber/WOPTO huggingface dataset:
Patent EP-3417066-A2 (EP)
Inventor: SMITH GARY
IPC: C12P7/24
Filed: 2017-02-17
Abstract: La présente divulgation concerne des procédés biocatalytiques permettant d'obtenir un produit, lesdits procédés consistant à introduire un flux aqueux (AS) comprenant au moins un substrat fermentable et un flux gazeux (GS) comprenant au moins un gaz parmi CO2/H2, H2, méthane, et/ou CO dans une zone de fermentation, où les flux GS et AS sont éventuellement mis en contact et/ou mélangés ; lesdits procédés étant caractérisés en ce que la zone de fermentation comprend au moins un organisme capable de métaboliser un substrat AS et un substrat GS, la fermentation s'opérant dans des conditions aptes à métaboliser par mixotrophie au moins un substrat gazeux dans le flux GS et au moins un substrat dans le flux AS, pour obtenir le produit. La présente divulgation concerne également des compositions comprenant un flux AS, un flux GS, et un organisme, où l'organisme ou un équivalent ou équivalent génétiquement modifié de celui-ci est un méthanotrophe ou un organisme chimiolithotrophe qui métabolise l'hydrogène ou métabolise le CO, et où l'organisme est capable de métaboliser par mixotrophie au moins un substrat gazeux dans le flux GS et au moins un substrat dans le flux AS. Dans un procédé selon la présente divulgation, ladite fermentation s'opère dans des conditions aptes à métaboliser par mixotrophie au moins le H2 dans le flux GS et le glycérol et l'acide lactique dans le flux aqueux. Un système de production d'une fermentation ou d'un produit biodérivé est en outre décrit.
Patent EP-3497809-A2 (EP)
Title: Rétroaction de csi avancée progressive
Inventor: GAO SHIWEI
IPC: H04B7/06
Filed: 2017-08-11
Abstract: L'invention concerne des procédés, des dispositifs sans fil, et des stations de base aptes à déterminer des informations d'état de canal (CSI) multi-faisceau. Selon un aspect, des modes de réalisation comprennent un procédé de détermination d'informations d'état de canal (CSI) multi-faisceau. Le procédé consiste à générer un premier rapport de CSI associé à un premier faisceau; et à générer un second rapport de CSI associé à un second faisceau, le second rapport de CSI comprenant au moins un coefficient de co-phasage entre les premier et second faisceaux.
Patent EP-3554595-A2 (EP)
Inventor: SANDERS LAURIE
IPC: A61M5/158
Filed: 2017-12-12
Abstract: A safety needle device is disclosed having a hub, needle cannula, housing, tether, retractable sleeve, locking member and spring element. The tether is movably disposed in the housing, the tether having a slot with an enlarged first guide path and a narrowed second guide path extending distally from the enlarged first guide path. The retractable sleeve is configured to move between an initial position, a retracted position and an extended position with respect to the housing, wherein the initial position partially exposes a distal tip of the needle cannula, the retracted position fully exposes the needle cannula, and the extended position fully covers the distal tip of the needle cannula. The proximal movement of one or more protrusions on the retractable sleeve, rotates the tether to move the at least one or more protrusions from the enlarged first guide path of the tether to the narrowed second guide path of the tether, this rotation activating the device.
Patent EP-3540048-A2 (EP)
Inventor: HAN KYUBOEM
IPC: A61K35/17
Filed: 2017-11-14
Abstract: The present invention relates to an NK cells and PBMC, both having increased cytotoxicity. Particularly, NK cells and PBMC which have exogenous mitochondria introduced thereinto potentiate the immune system of the human body to enhance a therapeutic effect on infectious diseases or cancer. Therefore, the NK cells and PBMC can be used in a composition for prevention or treatment of infectious diseases and cancer. Specially, autogenous NK cells and PBMC guarantee stability without the incurrence of an immune reaction, and thus would be expected to have high commercial activity.
Patent EP-3379804-A2 (EP)
Inventor: MATSUSHITA KATSUNORI
IPC: H04L29/08
Filed: 2018-03-16
Abstract: A secure data collection system includes a centralized management server, a first data collection system including a plurality of computing devices communicating with each other and a first communication interface connected to a public network, and a second data collection system including a plurality of computing devices communicating with each other and a second communication interface connected to the public network. The management server is connected to the public network and configured to enhance security of the first data collected and transmitted through the first communication interface by the first data collection system and second data collected and transmitted through the second communication interface by the second data collection system while converting the first data and the second data into composite data.
Patent EP-3457372-A2 (EP)
Inventor: NORTON ALEXANDRA K
IPC: G08B29/14
Filed: 2018-09-17
Abstract: A service management system facilitates and validates service on building management systems. A connected services database stores service events based on services performed on devices of different building management systems along with information about technicians performing the services, buildings containing the building management systems and devices being serviced. A service data aggregator retrieves the service events from the connected services database and generates prediction information and validation information based on the service events and other information. The prediction information includes a predicted duration and cost of different types of service as well as a predicted service interval for devices requiring periodic service. The validation information includes whether services performed by a particular technician need to be reviewed or audited, or whether the particular technician needs additional training or oversight, based on comparing the duration of services performed by the particular technician to the duration of services performed by all technicians.
Patent EP-3466449-A2 (EP)
Inventor: MIN KYUNGYOON
IPC: A61L2/00
Filed: 2018-10-04
Abstract: An integrated blood component collection and pathogen inactivation fluid circuit is disclosed.
Patent EP-3514842-A2 (EP)
Inventor: TSAI TSUNG-HAN
IPC: H01L33/62
Filed: 2018-12-10
Abstract: A display device is provided. The display device includes a substrate, a driving circuit disposed on the substrate, and a light-emitting unit disposed on the driving circuit and electrically connected to the driving circuit. The light-emitting unit includes a first semiconductor layer, a quantum well layer disposed on the first semiconductor layer and a second semiconductor layer disposed on the quantum well layer. The second semiconductor layer includes a first top surface. The display device also includes a first protective layer disposed on the driving circuit and adjacent to the light-emitting unit. The first protective layer includes a second top surface. The elevation of the first top surface is higher than the elevation of the second top surface.
Patent EP-3600248-A2 (EP)
Inventor: BEGOVAC PAUL C
IPC: A61K47/14
Filed: 2018-03-27
Abstract: The present disclosure is directed to injectable formulations that include biodegradable polymers based on trimethylene carbonate (TMC) with mole fractions of polylactic acid (PLA) and/or polyglycolic acid (PGA) that are used to deliver a bioactive agent to a targeted site. Excipients such as polyethylene glycol (PEG) may be added to the formulations to reduce the injection force and/or to modulate the release of the bioactive agent. Suitable biodegradable polymers for use in the injectable formulations include D,L-PLA:TMC, D-PLA:TMC, L-PLA:TMC, TMC:PLA:PGA and variations thereof. Additionally, copolymers of TMC and PLA and terpolymers of TMC:PLA:PGA may be formed into nanoparticles and delivered to the target site with an injectable crosslinkable polyethylene glycol system. In at least one embodiment, the injectable formulations are used to treat ocular diseases.
Patent EP-3599587-A2 (EP)
Inventor: WITHEY ROBERT KEITH JOHN
IPC: B33Y50/00
Filed: 2019-04-17
Abstract: A flood-fill method for parallel implementation comprises the steps of receiving an image comprising first elements having a flood fill source colour to be replaced with a flood fill target colour, and second elements not having the flood fill source colour; dividing the image according to a hierarchical space-partitioning scheme to form cells at a plurality of levels in the hierarchy; detecting the occupancy of each cell by second elements; for any cell having no occupancy by second elements, set a depth elevation value for child cells of that cell to be one greater than the value for that cell, indicating that the flood fill shall navigate levels towards a root cell by the depth elevation amount of a cell whilst only occupying nodes without any second elements, thereby reaching the largest parent cell which can be flood-filled; and filling the flood fill source colour of cells having no occupancy by second elements with the flood fill target colour, thereby modifying the received image.
Patent EP-3575745-A2 (EP)
Inventor: CARRINO JOHN
IPC: G01C21/20
Filed: 2019-05-28
Abstract: Systems, methods, and non-transitory computer readable media are provided for determining routes within a location. Location information for a location may be obtained. The location information may include terrain information for the location. A set of restricted regions within the location may be determined based on the location information. A set of paths within the location may be determined based on the set of restricted regions. An interface through which information describing the set of paths within the location is accessible may be provided.
Patent EP-3627547-A2 (EP)
Inventor: NARAYANASAMY JAYAGANASAN
IPC: H01L23/433
Filed: 2018-04-12
Abstract: A method for forming a composite layer on a workpiece is disclosed. In an embodiment, the method comprises forming a wall around a metallic surface such that the wall extends in a vertical direction from a plane formed by the metallic surface of a workpiece, depositing a filler material in a walled area on the metallic surface, depositing a plastic material on the filler material, and performing a vacuum treatment of the filler material and the plastic material thereby forming a matrix composite layer disposed on the metallic surface.
Patent EP-3870714-A2 (EP)
Inventor: NIKEL PABLO IVÁN
IPC: C12P19/40
Filed: 2019-10-23
Abstract: La présente invention concerne une cellule pouvant produire un composé fluoré, chloré ou bromé, des procédés de production de composés fluorés, chlorés ou bromés dans une cellule et des systèmes d'expression correspondants.
Patent EP-3849584-A2 (EP)
Inventor: MIRKIN CHAD A
IPC: A61K38/14
Filed: 2019-09-13
Abstract: La présente invention concerne, d'une manière générale, des procédés pour préparer des polymères de protéines. Les procédés consistent à utiliser des oligonucléotides pour réguler la voie d'association de protéines fonctionnalisées par des oligonucléotides en matériaux oligomères/polymères.
Patent EP-3761034-A2 (EP)
Inventor: SINGBARTL KAI
IPC: G01N33/68
Filed: 2012-01-20
Abstract: This invention is related to the field of the prevention and treatment of kidney disease. The treatment of kidney disease may be tailored depending upon the need for, or expectation of, renal recovery. For example, renal recovery can be determined by monitoring urine biomarkers related to the development of chronic kidney disease. For example, a normalized time course of approximately fourteen Days measuring urinary proteins can be used to establish the risk of recovery versus non-recovery in patient's having suffered an acute kidney injury. Alterantively, the invention describes signature protein expression profiles to establish the probability of renal recovery and/or renal non-recovery.
Patent EP-3741330-A2 (EP)
Inventor: HUTCHINS III BURLEIGH M
IPC: A61F2/82
Filed: 2011-08-05
Abstract: Ureteral stent devices having improved drug delivery capabilities are provided. The ureteral stent device includes a ureteral stent comprising two opposed ends, and a drug delivery component associated with at least one end of the ureteral stent. The drug delivery component includes a drug housing defining a drug reservoir containing a drug, wherein the drug housing is configured to release the drug in-vivo.
Patent EP-3930550-A2 (EP)
Inventor: MINARD JAMES J
IPC: A47J39/00
Filed: 2020-02-24
Abstract: A system to store food products within a heated compartment is provided. The system includes an enclosure that receives stacked trays, and an elevator to lift trays to a position to receive a plurality of food products from a conveyor or another source. A fork may be provided that receives a cooked food product thereon and rotates to allow the cooked food product to fall into the positioned tray while being maintained in a horizontal manner. A shuttle moves a full tray into a heated compartment, which moves trays therewithin to organize them for future use within a restaurant operation.
Patent EP-3955937-A2 (EP)
Inventor: HOLMES IAN
IPC: A61K31/70
Filed: 2020-04-16
Abstract: Described herein are compositions and methods for the treatment of ocular surface disorders including meibomian gland dysfunction, blepharitis, dry eye disease and other inflammatory/ infections disease of the anterior surface of the eye. Said compositions and methods comprise keratolytic conjugate which demonstrate keratolytic activity, and anti-inflammatory or other desirable activities. Topical administration of said compositions to the eye, ocular surface or surrounding areas provides therapeutic benefit to patients suffering from ocular surface disorders.
Patent EP-4007682-A2 (EP)
Title: Contreplaqué à matrice polymère
Inventor: BAKHSHANDEH AMIN
IPC: B27G11/00
Filed: 2020-07-15
Abstract: La présente invention concerne un contreplaqué à matrice polymère (PMP) qui se présente comme étant une connaissance technique de la fabrication et de l'utilisation d'une résine de polyoléfine (d'une part), pour la fabrication d'amorces, d'adhésifs et de peintures, avec un procédé à température ambiante et l'application dans les industries du bois et du plastique et le prétraitement de placages de bois minces et de construction de contreplaqué avec la possibilité de coller des couches de bois et de plastique ensemble et une pénétration efficace d'adhésif d'apprêt et de polyoléfine sur les surfaces de matériaux en bois et en matière thermoplastique, avec une pénétration et une saturation élevées de textures et de récipients en bois, pour la fabrication d'adhésifs et de peintures en polyoléfine recyclables et renouvelables pour le bois, avec la possibilité d'ajouter une conductivité électrique à une résine de polyoléfine et d'obtenir des propriétés anti-électrostatiques des surfaces résultantes, et de créer les conditions nécessaires pour le placage de surfaces en bois ou en matière plastique.
Patent EP-4008719-A2 (EP)
Inventor: WANG QIAN
IPC: A61K31/519
Filed: 2020-08-28
Abstract: Disclosed in the present invention are a pyrazolone and pyrimidine compound, and a preparation method and a use therefor. Provided in the present invention is a pyrazolone and pyrimidine compound as in formula (I), said compound having better inhibitory activity towards WEE1 kinase.
Patent EP-3919991-A2 (EP)
Inventor: KRISHNAN RAVI BHARATHI
IPC: G05B19/418
Filed: 2021-05-18
Abstract: A distributed building management system includes a virtual controller and an edge controller for controlling a building control device using a distributed control logic that is distributed between the virtual controller and the edge controller. A programming tool displays a graphical representation of the distributed control logic and identifies which portions of the distributed control logic are considered critical and which portions of the distributed control logic are considered not critical to a fail-safe operation of the building control device should the edge controller stop receiving control commands from the virtual controller. The portions of the distributed control logic that are identified as being critical are assigned to the edge controller for execution and the portions of the distributed control logic that are not identified as being critical are assigned to the virtual controller for execution.
Patent EP-4136230-A2 (EP)
Inventor: ANASTASSIADIS THEONIE
IPC: A61K31/7088
Filed: 2021-04-14
Abstract: The invention relates generally to tRNA-based effector molecules having a non-naturally occurring modification and methods relating thereto.
Patent EP-4139462-A2 (EP)
Inventor: DAIGLE TANYA
IPC: C12N15/864
Filed: 2021-04-21
Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. Particularly, the artificial expression constructs can be used to selectively express synthetic genes and / or modify gene expression in neocortical glutamatergic layer 5 neurons, such as glutamatergic layer 5 extratelencephalic-projecting (L5 ET) neurons.
Patent EP-4057357-A2 (EP)
Title: Display panel and manufacturing method thereof
Inventor: LEE HYESEUNG
IPC: H01L51/52
Filed: 2022-02-17
Abstract: A display panel may include first to third light emitting elements providing source light, first to third color filters, a first optical pattern between a first color filter and the first light emitting element, a second optical pattern between the second color filter and the second light emitting element, a third optical pattern between the third color filter and the third light emitting element, and a refractive layer between the first color filter and the first optical pattern, between the second color filter and the second optical pattern, and between the third optical pattern and the third light emitting element.
Patent EP-4233874-A2 (EP)
Title: Acetylsalicylic acid for reducing the risk of a thromboembolic event
Inventor: YADIDI KAMBIZ
IPC: A61K31/60
Filed: 2013-03-15
Abstract: Methods for reducing the risk of a thromboembolic event, and a related drug delivery system are provided. In some embodiments, a dose of acetylsalicylic acid can be provided in powder form to a patient using a dry powder inhaler. The dose can be effective to reduce a risk of a thromboembolic event in a patient. A dry powder inhaler used for the method can have a mouthpiece, a reservoir for receiving the dose of acetylsalicylic acid, and an actuation member for making available the dose of acetylsalicylic acid for inhalation by a patient through the mouthpiece.
Patent EP-4234272-A2 (EP)
Title: Pneumatic tire
Inventor: COCCON MARCO NICOLO
IPC: B60C9/28
Filed: 2020-12-15
Abstract: A pneumatic tire, preferably a pneumatic truck tire, comprising a tread, a carcass (18) and a belt package (40) interposed between the carcass (18) and the tread is disclosed. The belt package (40) includes a first working belt (41, 110), wherein the first working belt (41, 110) is the radially innermost belt and is the axially widest belt of the belt package (40), The belt package (40) further includes a relatively low angle belt (43, 120) located radially outward of the first working belt (41, 110) and comprising parallel reinforcement elements angled at an angle of less than 10 degrees with respect to the circumferential direction of the tire (10, 100). The relatively low angle belt (43, 120) is formed of a spirally wound strip comprising reinforcement cords. The relatively low angle belt (43, 120) is formed of a central portion (124) wherein the strips comprising the reinforcement cords are not overlapped, and an axially outer portion (122), preferably on each axially outer side of the central portion (120), wherein the strips comprising the reinforcement cords are overlapped. The reinforcement elements of the relatively low angle belt (43, 120) are extensible and/or the belt package (40) further includes a second working belt (45, 130) that is located radially outward of the relatively low angle belt (43, 120), the second working belt (45, 130) having a first lateral end section (46) and a second lateral end section (50).
Patent EP-4235658-A2 (EP)
Title: Downscaled decoding of audio signals
Inventor: SCHNELL MARKUS
IPC: G10L19/022
Filed: 2016-06-10
Abstract: A downscaled version of an audio decoding procedure may more effectively and/or at improved compliance maintenance be achieved if the synthesis window used for downscaled audio decoding is a downsampled version of a reference synthesis window involved in the non-downscaled audio decoding procedure by downsampling by the downsampling factor by which the downsampled sampling rate and the original sampling rate deviate, and downsampled using a segmental interpolation in segments of 1/4 of the frame length.
Patent EP-4236133-A2 (EP)
Title: Configuration of control channels in a mobile communication system
Inventor: SUZUKI HIDETOSHI
IPC: H04L1/00
Filed: 2007-12-10
Abstract: The invention relates to a method, apparatus and system for configuring control channels in a mobile communication network and a mobile station. In order to suggest another improved scheme for configuring control channels, in particular control channels related to the transmission of user data the invention suggests aligning the size of the control channel information of different formats to an equal number of coded control channel information bits and/or modulation symbols for each control channel. The control channels may comprise scheduling related control information. According to another aspect of the invention, a more flexible solution is proposed that may allow for taking different geometries of mobile stations within a cell into account. Similar to the aspect above, the size of the control channel information is aligned by means of modulation and/or coding, however the control channel information is aligned to one out of a set of numbers of coded control channel information bits and/or modulation symbols for each control channel.
Patent EP-0002804-A2 (EP)
Inventor: STRAUB FERDINAND DR
IPC: A61K31/79
Filed: 1978-12-21
Abstract: Die Erfindung betrifft hochmolekulare Produkte auf Basis von N-Vinylpyrrolidon, in denen Blöcke von Vinylpyrrolidonpolymerisaten oder Vinylpyrrolidoncopolymerisaten durch Ester-, Amid-, Urethan- oder Harnstoff-Gruppen tragende Zwischenglieder verknüpft sind, wodurch diese hochmolekularen Produkte biologisch abbaubar sind und sich für Blutersatzflüssigkeiten eignen, sowie solche Blutersatzflüssigkeiten.
Patent EP-0001197-A2 (EP)
Title: Produits de couplage de la cytidine-diphosphocholine et de composés aminés, procédé d'obtention et application pharmaceutique et analytique
Inventor: PERY PIERRE
IPC: G01N33/531
Filed: 1978-09-05
Abstract: Les produits de couplage de la cytidine-diphosphocholine avec des composés aminés sont obtenus par le procédé qui consiste: à oxyder de la cytidine-diphosphocholine, à fixer le dialdéhyde ebtenu par l'oxydation précédente du ribose de la cytidine sur les groupements NH2 du composé aminé en solution aqueuse alcaline, à stabiliser le couplage ainsi réalisé par réduction et à récupérer le produit macromoléculaire ainsi obtenu sous la forme d'une solution aqueuse, celle-ci pouvant être lyophilisée pour fournir une poudre apte à la conservation. Le couplage se fait entre les groupes ribose oxydés de la cytidine-diphosphocholine et les résidus lysine des composés aminés. Les produits de l'invention conviennent notamment comme vaccins contre les parasites appartenant à la classe de ceux comportant des molécules liées à un résidu phosphorylcholine, tels que des parasites intestinaux ou respiratoires. Ils conviennent également au dosage de composés biologiques réagissant avec la phosphorylcholine.